世界および米国の好酸球性喘息治療薬の市場規模、現状および見通し 2021-2027年Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027 市場分析と洞察。好酸球性喘息治療薬の世界市場 当レポートでは、世界および米国の好酸球性喘息治療薬市場に焦点を当てています。 2020年の好酸球性喘息治療の世界市場規模は9901百万米ドルで、2021-2027年の間... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場分析と洞察。好酸球性喘息治療薬の世界市場当レポートでは、世界および米国の好酸球性喘息治療薬市場に焦点を当てています。 2020年の好酸球性喘息治療の世界市場規模は9901百万米ドルで、2021-2027年の間に38.99%のCAGRで、2027年末には98355百万米ドルに達すると予想されています。米国では、好酸球性喘息治療薬の市場規模は、2020年の3590百万米ドルから2027年には38112百万米ドルまで、予測期間中に40.24%のCAGRで成長すると予測されています。 世界の好酸球性喘息治療薬のスコープと市場規模 好酸球性喘息治療薬市場は、プレイヤー別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のEosinophilic Asthma Treatment市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。 企業別 ジェネンテック(ロシュ・グループ)&ノバルティス Regeneron Pharmaceuticals&Sanofi ジーエスケー アストラゼネカ テバ社 タイプ別セグメント 点滴静注 皮下注射 用途別セグメント 子供 ティーンエイジャー 大人 地域別 北アメリカ アメリカ カナダ アジア太平洋 日本 インド 東南アジア オーストラリア その他 ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 ラテンアメリカ メキシコ ブラジル 中近東・アフリカ 中近東 アフリカ 目次1 REPORT OVERVIEW 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1 1.2.2 Intravenous Infusion 2 1.2.3 Subcutaneous Injection 3 1.3 Market by Application 3 1.3.1 Global Eosinophilic Asthma Treatment Market Share by Application: 2016 VS 2021 VS 2027 4 1.3.2 Children 5 1.3.3 Teenagers 5 1.3.4 Adults 5 1.4 Study Objectives 6 1.5 Years Considered 7 2 GLOBAL GROWTH TRENDS 8 2.1 Global Eosinophilic Asthma Treatment Market Perspective (2016-2027) 8 2.2 Eosinophilic Asthma Treatment Growth Trends by Regions 9 2.2.1 Eosinophilic Asthma Treatment Market Size by Regions: 2016 VS 2021 VS 2027 9 2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Regions (2016-2021) 10 2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027) 11 2.2.4 United States Eosinophilic Asthma Treatment Market Share in Global Market 2016-2027 12 2.3 Eosinophilic Asthma Treatment Industry Dynamic 13 2.3.1 Eosinophilic Asthma Treatment Market Trends 13 2.3.2 Eosinophilic Asthma Treatment Market Drivers 13 2.3.3 Eosinophilic Asthma Treatment Market Challenges 13 2.3.4 Eosinophilic Asthma Treatment Market Restraints 14 3 THE NUMBER OF PATIENTS OF EOSINOPHILIC ASTHMA BY REGIONS 15 3.1 The Number of Patients of Eosinophilic Asthma by Regions (2019-2021) 15 3.2 The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021) 15 4 COMPETITION LANDSCAPE BY KEY PLAYERS 16 4.1 Global Top Eosinophilic Asthma Treatment Players by Revenue 16 4.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2016-2021) 16 4.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2016-2021) 16 4.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17 4.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue 18 4.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio 18 4.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR3 and HHI) 18 4.4.2 Global Top 3 Companies by Eosinophilic Asthma Treatment Revenue in 2020 19 4.5 Eosinophilic Asthma Treatment Key Players Head office 20 4.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service 20 4.7 Date of Enter into Eosinophilic Asthma Treatment Market 20 4.8 Mergers & Acquisitions, Expansion Plans 21 5 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE 22 5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2016-2021) 22 5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027) 23 6 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION 24 6.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2016-2021) 24 6.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027) 25 7 NORTH AMERICA 26 7.1 North America Eosinophilic Asthma Treatment Market Size (2016-2027) 26 7.2 North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 26 7.3 North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 27 7.4 North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 27 7.4.1 United States 28 7.4.2 Canada 29 8 EUROPE 30 8.1 Europe Eosinophilic Asthma Treatment Market Size (2016-2027) 30 8.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 30 8.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 31 8.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 31 8.4.1 Germany 32 8.4.2 France 33 8.4.3 U.K. 33 8.4.4 Italy 34 8.4.5 Russia 34 8.4.6 Spain 35 9 ASIA-PACIFIC 36 9.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2016-2027) 36 9.2 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 36 9.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 37 9.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 37 9.4.1 Japan 38 9.4.2 India 39 9.4.3 Southeast Asia 39 9.4.4 Australia 40 10 LATIN AMERICA 41 10.1 Latin America Eosinophilic Asthma Treatment Market Size (2016-2027) 41 10.2 Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 41 10.3 Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 42 10.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 42 10.4.1 Mexico 43 10.4.2 Brazil 44 11 MIDDLE EAST & AFRICA 45 11.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2016-2027) 45 11.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 45 11.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 46 11.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 47 11.4.1 Middle East 47 11.4.2 Africa 48 12 KEY PLAYERS PROFILES 49 12.1 Genentech(Roche Group)&Novartis 49 12.1.1 Genentech(Roche Group) Company Details 49 12.1.2 Genentech(Roche Group) Business Overview 49 12.1.3 Novartis Company Details 50 12.1.4 Novartis Business Overview 50 Sandoz Department 50 12.1.5 Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Introduction 51 12.1.6 Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 51 12.2 Regeneron Pharmaceuticals&Sanofi 52 12.2.1 Regeneron Pharmaceuticals Company Details 52 12.2.2 Regeneron Pharmaceuticals Business Overview 53 12.2.3 Sanofi Company Details 53 12.2.4 Sanofi Business Overview 53 12.2.5 Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Introduction 54 12.2.6 Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 54 12.3 GlaxoSmithKline 55 12.3.1 GlaxoSmithKline Company Details 55 12.3.2 GlaxoSmithKline Business Overview 56 12.3.3 GlaxoSmithKline Eosinophilic Asthma Treatment Introduction 56 12.3.4 GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 57 12.4 AstraZeneca 57 12.4.1 AstraZeneca Company Details 57 12.4.2 AstraZeneca Business Overview 58 12.4.3 AstraZeneca Eosinophilic Asthma Treatment Introduction 58 12.4.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 59 12.5 Teva Pharmaceutical Industries Ltd. 60 12.5.1 Teva Pharmaceutical Industries Ltd. Company Details 60 12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview 60 12.5.3 Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Introduction 60 12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 61 13 ANALYST'S VIEWPOINTS/CONCLUSIONS 63 14 APPENDIX 64 14.1 Research Methodology 64 14.1.1 Methodology/Research Approach 64 14.1.2 Data Source 67 14.2 Disclaimer 70 14.3 Author Details 70
SummaryMarket Analysis and Insights: Global Eosinophilic Asthma Treatment Market Table of Contents1 REPORT OVERVIEW 11.1 Study Scope 1 1.2 Market Analysis by Type 1 1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1 1.2.2 Intravenous Infusion 2 1.2.3 Subcutaneous Injection 3 1.3 Market by Application 3 1.3.1 Global Eosinophilic Asthma Treatment Market Share by Application: 2016 VS 2021 VS 2027 4 1.3.2 Children 5 1.3.3 Teenagers 5 1.3.4 Adults 5 1.4 Study Objectives 6 1.5 Years Considered 7 2 GLOBAL GROWTH TRENDS 8 2.1 Global Eosinophilic Asthma Treatment Market Perspective (2016-2027) 8 2.2 Eosinophilic Asthma Treatment Growth Trends by Regions 9 2.2.1 Eosinophilic Asthma Treatment Market Size by Regions: 2016 VS 2021 VS 2027 9 2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Regions (2016-2021) 10 2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027) 11 2.2.4 United States Eosinophilic Asthma Treatment Market Share in Global Market 2016-2027 12 2.3 Eosinophilic Asthma Treatment Industry Dynamic 13 2.3.1 Eosinophilic Asthma Treatment Market Trends 13 2.3.2 Eosinophilic Asthma Treatment Market Drivers 13 2.3.3 Eosinophilic Asthma Treatment Market Challenges 13 2.3.4 Eosinophilic Asthma Treatment Market Restraints 14 3 THE NUMBER OF PATIENTS OF EOSINOPHILIC ASTHMA BY REGIONS 15 3.1 The Number of Patients of Eosinophilic Asthma by Regions (2019-2021) 15 3.2 The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021) 15 4 COMPETITION LANDSCAPE BY KEY PLAYERS 16 4.1 Global Top Eosinophilic Asthma Treatment Players by Revenue 16 4.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2016-2021) 16 4.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2016-2021) 16 4.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17 4.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue 18 4.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio 18 4.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR3 and HHI) 18 4.4.2 Global Top 3 Companies by Eosinophilic Asthma Treatment Revenue in 2020 19 4.5 Eosinophilic Asthma Treatment Key Players Head office 20 4.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service 20 4.7 Date of Enter into Eosinophilic Asthma Treatment Market 20 4.8 Mergers & Acquisitions, Expansion Plans 21 5 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE 22 5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2016-2021) 22 5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027) 23 6 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION 24 6.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2016-2021) 24 6.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027) 25 7 NORTH AMERICA 26 7.1 North America Eosinophilic Asthma Treatment Market Size (2016-2027) 26 7.2 North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 26 7.3 North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 27 7.4 North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 27 7.4.1 United States 28 7.4.2 Canada 29 8 EUROPE 30 8.1 Europe Eosinophilic Asthma Treatment Market Size (2016-2027) 30 8.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 30 8.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 31 8.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 31 8.4.1 Germany 32 8.4.2 France 33 8.4.3 U.K. 33 8.4.4 Italy 34 8.4.5 Russia 34 8.4.6 Spain 35 9 ASIA-PACIFIC 36 9.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2016-2027) 36 9.2 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 36 9.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 37 9.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 37 9.4.1 Japan 38 9.4.2 India 39 9.4.3 Southeast Asia 39 9.4.4 Australia 40 10 LATIN AMERICA 41 10.1 Latin America Eosinophilic Asthma Treatment Market Size (2016-2027) 41 10.2 Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 41 10.3 Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 42 10.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 42 10.4.1 Mexico 43 10.4.2 Brazil 44 11 MIDDLE EAST & AFRICA 45 11.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2016-2027) 45 11.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 45 11.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 46 11.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 47 11.4.1 Middle East 47 11.4.2 Africa 48 12 KEY PLAYERS PROFILES 49 12.1 Genentech(Roche Group)&Novartis 49 12.1.1 Genentech(Roche Group) Company Details 49 12.1.2 Genentech(Roche Group) Business Overview 49 12.1.3 Novartis Company Details 50 12.1.4 Novartis Business Overview 50 Sandoz Department 50 12.1.5 Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Introduction 51 12.1.6 Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 51 12.2 Regeneron Pharmaceuticals&Sanofi 52 12.2.1 Regeneron Pharmaceuticals Company Details 52 12.2.2 Regeneron Pharmaceuticals Business Overview 53 12.2.3 Sanofi Company Details 53 12.2.4 Sanofi Business Overview 53 12.2.5 Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Introduction 54 12.2.6 Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 54 12.3 GlaxoSmithKline 55 12.3.1 GlaxoSmithKline Company Details 55 12.3.2 GlaxoSmithKline Business Overview 56 12.3.3 GlaxoSmithKline Eosinophilic Asthma Treatment Introduction 56 12.3.4 GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 57 12.4 AstraZeneca 57 12.4.1 AstraZeneca Company Details 57 12.4.2 AstraZeneca Business Overview 58 12.4.3 AstraZeneca Eosinophilic Asthma Treatment Introduction 58 12.4.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 59 12.5 Teva Pharmaceutical Industries Ltd. 60 12.5.1 Teva Pharmaceutical Industries Ltd. Company Details 60 12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview 60 12.5.3 Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Introduction 60 12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 61 13 ANALYST'S VIEWPOINTS/CONCLUSIONS 63 14 APPENDIX 64 14.1 Research Methodology 64 14.1.1 Methodology/Research Approach 64 14.1.2 Data Source 67 14.2 Disclaimer 70 14.3 Author Details 70
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(アレルギー用薬)の最新刊レポート
QYResearch社のアレルギー用薬分野での最新刊レポート
本レポートと同じKEY WORD(asthma)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |